Dr. Chen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2330 Inwood Rd Biocenter
Dallas, TX 75390Phone+1 214-648-4791Fax+1 916-734-2560
Summary
- Dr. Mingyi Chen is a pathologist in Irving, TX and is affiliated with University of Texas Southwestern Medical Center. He received his medical degree from Beijing Medical University and has been in practice 20 years. He specializes in hematopathology, anatomic pathology, and clinical pathology.
Education & Training
- City of Hope National Medical CenterFellowship, Hematopathology, 2009 - 2010
- Beijing Medical UniversityClass of 1992
Certifications & Licensure
- TX State Medical License 2017 - 2026
- CA State Medical License 2007 - 2025
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- 124 citationsThe Phospholipid Transfer Protein Gene Is a Liver X Receptor Target Expressed by Macrophages in Atherosclerotic LesionsBryan A. Laffitte, Sean B. Joseph, Mingyi Chen, Antonio Castrillo, Joyce J. Repa
Molecular and Cellular Biology. 2003-03-15 - 101 citationsLoss of EZH2 Reprograms BCAA Metabolism to Drive Leukemic TransformationZhimin Gu, Yuxuan Liu, Feng Cai, McKenzie Patrick, Jakub Zmajkovic
Cancer Discovery. 2019-01-01 - 1 citationsIsoform-specific disruption of thegene reveals a critical role for TAp73γ in tumorigenesis via leptin.Xiangmudong Kong, Wensheng Yan, Wenqiang Sun, Yanhong Zhang, Hee Jung Yang
Elife. 2023-08-31
Committees
- member, Texas Society of Pathology Educational Committee 2021 - 2024
Research History
- ProfessorRESEARCH INTERESTS • Biomarker development of cancer diagnosis, cancer stem cells, immunotherapy. • Molecular pathogenesis of lymphoma and leukemia, tumor immunology and GVHD • Atherosclerosis, thrombosis, vascular biology, sickle cell disease and lipid metabolism2009 - 2030
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: